Genmab A (GMAB) Retained Earnings (2023 - 2026)
Genmab A's Retained Earnings was $4.42 billion in the quarter ended Jun 30, 2026, up 8.1% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Retained Earnings (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Retained Earnings at Genmab A came in at $4.1 billion, up 20.8% from the prior year.
- Retained Earnings has now increased for six consecutive years, with a five-year compound annual growth rate of 37.8% (years ended Dec 2020 to Dec 2025).
- In earlier years, Retained Earnings was $3.39 billion in the year ended Dec 31, 2024 (+23.9%), $2.74 billion in the year ended Dec 31, 2023 (+98.1%), $1.38 billion in the year ended Dec 31, 2022 (+22.1%) and $1.13 billion in the year ended Dec 31, 2021 (+37.1%).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Retained Earnings since the quarter ended Sep 30, 2020.
- The best year-over-year quarter for Retained Earnings over five years was the quarter ended Sep 30, 2025 (growth of 114.0%); the worst was the quarter ended Sep 30, 2021 (a decline of 83.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 31.89 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 171.67 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -17.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 63.27 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 12.59 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -22.28 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 2.20 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 112.09 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn | 4.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.42 Bn |
| Mar 31, 2026 | 4.09 Bn |
| Dec 31, 2025 | 4.10 Bn |
| Sep 30, 2025 | 4.03 Bn |
| Jun 30, 2025 | 3.60 Bn |
| Mar 31, 2025 | 3.54 Bn |
| Dec 31, 2024 | 3.39 Bn |
| Dec 31, 2023 | 2.74 Bn |
| Jan 1, 2023 | 2.13 Bn |
API Access
Genmab A Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();